PharmaBoardroom

Christoforos Hadjikyprianou – CEO, European University Cyprus

Christoforos Hadjikyprianou of the European University Cyprus, home to the island’s only state-of-the-art medical school, explains the…

Geoffrey Guy, Chairman, GW Pharma

Dr. Geoffrey Guy, chairman and founder of cannabinoid medicine pioneer, GW Pharma, outlines the potential benefits that Brexit could bring to the…

Brexit Bites: EMA cuts off Britain

The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been working on a cancer drug for…

Zoubir Harrat – General Manager, Institut Pasteur in…

Dr. Zoubir Harrat heads the Institut Pasteur d’Algérie (IPA), after having spent most of his career with the institution. He talks of the…

Russian bots targeted US and vaccines

In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls…

Brexit: Much Ado About Nothing?

Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect. As the UK’s impending withdrawal…

David Garway-Heath – Moorfields Eye Hospital, UK

Professor David Garway-Heath, a specialist in glaucoma, talks with us about the screening devices of the future, low awareness of glaucoma as a…

Lars Bruening, CEO, Bayer UK & Ireland

After spending five years heading market access globally, Lars Bruening returned to a country manager role in the UK; he shares with us his thoughts…

UK Charities: The Funding Giants of Medical Research

One notable quirk of the British life sciences ecosystem is the importance of its not-for-profit sector. Indeed, in 2017, UK charities poured GBP 1.6…